Urolithiasis and Nephrocalcinosis in Childhood

Comprehensive Pediatric Nephrology

Volumn , Issue , 2008, Pages 499-525

  Hoppe, Bernd ^a   Leumann, Ernst ^b   Milliner, Dawn S ^c  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882870953     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04883-5.50039-8     Document Type: Chapter

References (133)

1. Saigal CS, Joyce G, Timilsina AR Urologic Diseases in America Project: Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management. Kidney Int 2005, 68:1808-1814.
2. Ganem JP, Carson CC Frere Jacques Beaulieu: from rogue lithot-omist to nursery rhyme character. J Urol 1999, 161:1067-1069.
3. Hesse A Urinary calculi 1: epidemiology, laboratory diagnosis, genetics and infections. Urologe A 2002, 41:496-508.
4. Coe FL, Evan A, Worcester E Kidney stone disease. J Clin Invest 2005, 115:2598-2608.
5. Carson PJ, Brewster DR Unique pattern of urinary tract calculi in Australian Aboriginal children. J Paediatr Child Health 2003, 39:325-328.
6. Bartosh SM Medical management of pediatric stone disease. Urol Clin North Am 2004, 31:575-587.
7. Sarica K Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res 2006, 34:96-101.
8. Sarkissian A, Babloyan A, Arikyants N, et al. Pediatric urolithiasis in Armenia: a study of 198 patients observed from 1991 to 1999. Pediatr Nephrol 2001, 16:728-732.
9. Edvardsson V, Elidottir H, Indridason OS, Palsson R High incidence of kidney stones in Icelandic children. Pediatr Nephrol 2005, 20:940-944.
10. Papatsoris AG, Varkarakis I, Dellis A, Dliveliotis C Bladder lithiasis: from open surgery to lithotripsy. Urol Res 2006, 34:163-167.
11. Van Woerden CS, Groothoff JW, Wanders RJ Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003, 18:273-279.
12. Hoppe B, Latta K, von Schnakenburg C, Kemper MJ Primary hyperoxaluria-the German experience. Am J Nephrol 2005, 25:276-281.
13. Leumann E, Hoppe B Urolithiasis in childhood. Therapeutic strategies in children with renal disease 1997, 655-674. Baillière's Clinical Paediatrics, London. W. Proesmans (Ed.).
14. Smith RC, Rosenfield AT, Choe KA, et al. Acute flank pain: comparison of non-contrast-enhanced CT and intravenous urography. Radiology 1995, 194:789-794.
15. Mindell HJ, Cochran ST Current perspectives in the diagnosis and treatment of urinary stone disease. Am J Roentgenol 1994, 163:1314-1315.
16. Alon US Nephrocalcinosis. Pediatrics 1997, 9:160-165.
17. Cramer B, Husa L, Pushpanathan C Nephrocalcinosis in rabbits-correlation of ultrasound, computed tomography, pathology and renal function. Pediatr Radiol 1998, 28:9-13.
18. van't Hoff WG Aetiological factors in paediatric urolithiasis. Nephron Clin Pract 2004, 98:45-48.
19. Cameron MA, Sakkhae K, Moe OW Nephrolithiasis in children. Pediatr Nephrol 2005, 20:1587-1592.
20. Battino BS, DeFoor W, Coe F, et al. Metabolic evaluation of children with urolithiasis: are adult references for supersaturation appropriate. J Urol 2002, 168:2568-2571.
21. Defoor W, Asplin J, Jackson E, et al. Results of a prospective trial to compare normal urine supersaturation in children and adults. J Urol 2005, 174:1708-1710.
22. Parks JH, Goldfisher E, Asplin JR, Coe FL A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 2002, 167:1607-1612.
23. Sayer JA, Carr G, Simmons NL Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci 2004, 106:549-561.
24. Ronnefarth G, Misselwitz J Nephrocalcinosis in children: a retrospective study. Pediatr Nephrol 2000, 14:1016-1021.
25. Schell-Feith EA, van Holthe KJE, Conneman N, et al. Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters. Kidney Int 2000, 58:2102-2110.
26. Sikora P, Roth B, Kribs A, et al. Hypocitraturia is one of the major risk factors for nephrocalcinosis in very low birth weight (VLBW) infants. Kidney Int 2003, 63:2194-2199.
27. Downing G, Egelhoff JC, Daily DK, et al. Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years. J Pediatr 1992, 120:599-604.
28. Monge M, Garcia-Nieto VM, Domenech E, et al. Study of renal metabolic disturbances related to renal lithiasis at school age in very-low-birth-weight children. Nephron 1998, 79:269-273.
29. Neuhaus TJ, Belzer T, Blau N, et al. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 2000, 82:322-326.
30. Gwinner W, Suppa S, Mengel M, et al. Early calcifications of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant 2005, 5:1934-1941.
31. Stapenhorst L, Sassen R, Beck B, et al. Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation. Pediatr Nephrol 2005, 20:652-656.
32. Verkoelen CF, van der Boom BG, Houtsmuller AB, et al. Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 1998, 274:F958-F965.
33. Evan AP, Coe FK, Lingeman JE, et al. Insights on the pathology of kidney stone formation. Urol Res 2005, 33:383-389.
34. Moe OW Kidney stones: pathophysiology and medical management. Lancet 2006, 367:333-344.
35. Amaro CR, Goldberg J, Amaro JL, Padovani CR Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 2005, 31:29-33.
36. Damasio B, Massarino F, Durand F, et al. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis. J Nephrol 2005, 18:262-266.
37. Mir S, Serdaroglu E Quantification of hypercalciuria with the urine calcium osmolality ratio in children. Pediatr Nephrol 2005, 20:1562-1565.
38. Matos V, van Melle G, Boulat O, et al. Urinary phosphate/creati-nine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr 1997, 131:252-257.
39. Aladjem M, Barr J, Lahat E, Bistritzer T Renal and absorptive hypercalciuria: a metabolic disturbance with varying and interchanging modes of expression. Pediatrics 1996, 97:216-219.
40. Goldfarb DS, Fischer ME, Keich Y, Goldberg J A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 2005, 67:1053-1061.
41. Bushinsky DA, Asplin JR, Grynpas MD, et al. Calcium oxalate stone formation in genetic hypercalciuric stone forming rats. Kidney Int 2002, 61:975-987.
42. Hamm LL Renal handling of citrate. Kidney Int 1990, 38:728-735.
43. Jiang Z, Asplin JR, Evan AP, et al. Calcium oxalate urolithiasis in mice lacking anion transporter SLC26A6. Nat Genet 2006, 38:474-478.
44. Zanchetta JF, Rodriguez G, Negir AL, et al. Bone mineral density in patients with hypercalciuric nephrolithiasis. Nephron 1996, 73:557-560.
45. Campfield T, Braden G Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition. Pediatrics 1989, 84:860-863.
46. Holmes RP, Goodman HO, Assimos DG Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001, 59:270-276.
47. Van Woerden CS, Groothoff JW, Wijburg FA, et al. Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 2004, 66:746-752.
48. Leumann E, Hoppe B The primary hyperoxalurias. J Am Soc Nephrol 2001, 12:1986-1993.
49. Lieske JC, Monico CG, Holmes WS, et al. International registry for primary hyperoxaluria and Dent's disease. Am J Nephrol 2005, 25:290-296.
50. Khan SR Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 2004, 8:75-88.
51. Milliner DS, Eickholt JT, Bergstralh EJ, et al. Results of long term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 1994, 331:1553-1558.
52. Hoppe B, Kemper MJ, Bökenkamp A, et al. Plasma calcium-oxalate supersaturation in children with primary hyperoxaluria and end stage renal disease. Kidney Int 1999, 56:268-274.
53. Hoppe B, Graf D, Offner G, et al. Oxalic acid elimination in children with chronic renal failure: comparison between hemodialysis and peritoneal dialysis. Pediatr Nephrol 1996, 10:488-492.
54. Hoppe B, Langman C A United States survey on diagnosis, treatment and outcome of patients with primary hyperoxaluria. Pediatr Nephrol 2003, 18:986-991.
55. Milliner DS The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol 2005, 25:154-160.
56. Cochat P, Liutkus A, Fargue S, et al. Primary hyperoxaluria type 1: still challengingl. Pediatr Nephrol 2006, 21:1075-1081.
57. Rumsby G, Williams E, Coulter-Mackie M Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 2004, 66:959-963.
58. Monico CG, Rossetti S, Olson JB, Milliner DS Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 2005, 67:1704-1709.
59. Milliner DS, Wilson DM, Smith LH Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int 2001, 59:31-36.
60. Monico CG, Persson M, Ford GC, et al. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 2002, 62:392-400.
61. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993, 328:833-838.
62. Hatch M, Freel RW Intestinal transport of an obdurate anion: oxalate. Urol Res 2005, 33:1-16.
63. Hatch M, Freel RW, Vaziri ND Regulatory aspects of oxalate secretion in enteric oxalate elimination. J Am Soc Nephrol 1999, 10:S324-S328.
64. Hoppe B, Leumann E, von Unruh G, et al. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 2003, 8:e437-e443.
65. Miller LA, Stapleton FB Urinary citrate excretion in patients with hypercalciuria. J Pediatr 1985, 107:263-266.
66. Tekin A, Tekgul S, Atsu N, et al. A study of the etiology of idio-pathic calcium urolithiasis in children: hypocitraturia is the most important risk factor. J Urol 2000, 164:162-165.
67. Parks JH, Coe FL A urinary calcium-citrate index for the evaluation on nephrolithiasis. Kidney Int 1986, 30:85-90.
68. Preminger GM, Sakhaee K, Skurla C, Pak CYC Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 1985, 134:20-24.
69. Hoppe B, von Unruh GE, Blank G, et al. Absorptive hyperoxaluria leads to an increased risk of urolithiasis or nephrocalcinosis in cystic fibrosis. Am J Kid Dis 2005, 46:440-445.
70. Sakhaee K, William RH, Oh MS, et al. Alkali absorption and citrate excretion in calcium nephrolithiasis. J Bone Miner Res 1993, 8:789-794.
71. Parks JH, Worcester EM, Coe FL, et al. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 2004, 66:777-785.
72. Bouropoulos N, Mouzakis DE, Bithelis G, Liatsikos E Vickers hardness studies of calcium oxalate monohydrate and brushite urinary stones. J Endourol 2006, 20:59-63.
73. Saadi I, Chen XZ, Hediger M, et al. Molecular genetics of cystin-uria: mutation analysis of SLC3A1 and evidence for another gene in type I (silent) phenotype. Kidney Int 1998, 54:48-55.
74. Leclerc D, Boutros M, Suh D, et al. SLC7A9 mutations in all three cystinuria subtypes. Kidney Int 2002, 62:1550-1559.
75. Font-Llitjos M, Jimenez-Vidal M, Bisceglia L, et al. New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 2005, 42:58-68.
76. Goodyer P, Saadi I, Ong P, et al. Cystinuria subtype and the risk of nephrolithiasis. Kidney Int 1998, 54:56-61.
77. Boutros M, Vicanek C, Rozen R, Goodyer P Transient neonatal cystinuria. Kidney Int 2005, 67:443-448.
78. Rodriguez LM, Santos F, Malaga S, Martinez V Effect of a low sodium diet on urinary elimination of cystine in cystinuric children. Nephron 1995, 71:416-418.
79. Dello Strologo L, Pras E, Pontesilli C, et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 2002, 13:2547-2553.
80. Restaino I, Kaplan BS, Stanley C, Baker L Nephrolithiasis, hypocitraturia, and a distal renal tubular acidification defect in type 1 glycogen storage disease. J Pediatr 1993, 122:392-396.
81. Arnodottir M, Laxdal T, Halldorsdottir B 2,8-dihydroxyadenin-uria: are there no cases in Scandinavia. Scand J Urol Nephrol 2005, 39:82-86.
82. Sahota AS, Tischfield JA, Katamani N, Simmonds HA Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadenine lithiasis. The metabolic bases of inherited disease 2001, 2571-2584. McGraw Hill, New York. C.R. Scriver, A.L. Beaudet, D. Valle, W.S. Sly (Eds.).
83. Arikyants N, Sarkissian A, Hesse A, et al. Xanthinuria type I-a rare cause of urolithiasis. Pediatr Nephrol 2007, 22:310-314.
84. Bradbury MG, Henderson M, Brocklebank JT, Simmonds HA Acute renal failure due to xanthine stones. Pediatr Nephrol 1995, 9:476-477.
85. Badertscher E, Robson WL, Leung AK, Trevenen CL Xanthine calculi presenting at 1 month of age. Eur J Pediatr 1993, 152:252-254.
86. Cohen TD, Preminger GM Struvite calculi. Semin Nephrol 1996, 16:425-436.
87. Matlaga BR, Kim SC, Watkins SL, et al. Changing composition of renal calculi in patients with neurogenic bladder. J Urol 2006, 175:1716-1719.
88. Bajwa ZH, Gupta S, Warfield CA, Steinman TI Pain management in poly cystic kidney disease. Kidney Int 2001, 60:1631-1644.
89. Sayasone S, Odermatt P, Khammanivong K, et al. Bladder stones in childhood: a descriptive study in a rural setting in Caravan Province, Lao PDR. Southeast Asian J Trop Med Public Health 2004, 35(Suppl 2):50-52.
90. Landau D, Tovbin D, Shalev H Pediatric urolithiasis in southern Israel: the role of uricosuria. Pediatr Nephrol 2000, 14:1105-1110.
91. Balla AA, Salah AM, Khattab AH, et al. Mineral composition of renal stones from the Sudan. Urol Int 1998, 61:154-156.
92. Daudon M, Estepa L Drug induced lithiases. Presse Med 1998, 11:675-683.
93. Jacinto JS, Modanlou HD, Crade M, et al. Renal calcification incidence in very low birth weight infants. Pediatrics 1988, 81:31-35.
94. Zinn HL, Orentlicher RJ, Haller JO, Cohen HL Radiographically occult ureteral calculi in an HIV-positive child undergoing indinavir therapy. Emerg Radiol 2000, 7:114-116.
95. Hylander B, Kjellstrand CM Prognostic factors and treatment of severe ethylene glycol intoxication. Intensive Care Med 1996, 22:546-552.
96. Meier M, Nitschke M, Perras B, Steinhoff J Ethylene glycol intoxication and xylitol infusion-metabolic steps of oxalate-induced acute renal failure. Clin Nephrol 2005, 63:225-228.
97. Okuonghae HO, Ighogboja IS, Lawson JO, Nwana EJ Diethylene glycol poisoning in Nigerian children. Ann Trop Paediatr 1992, 12:235-238.
98. Daudon M, Réveillaud RJ Piridoxilate-associated calcium oxalate urinary calculi, a new metabolic drug induced nephrolithiasis. Lancet 1985, 1:1338.
99. Wong K, Thomson C, Bailey RR, et al. Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med 1994, 24:410-411.
100. Sanz P, Reig R Clinical and pathological findings in fatal plant oxalosis. Am J Forensic Med Pathol 1992, 13:342-345.
101. Chen CL, Fang HC, Chou KJ, et al. Acute oxalate nephropathy after ingestion of star fruit. Am J Kid Dis 2001, 37:418-422.
102. Farre M, Xirgu J, Salgado A, et al. Fatal oxalic acid poisoning from sorrel soup. Lancet 1989, 2:8678-8679.
103. Worcester EM Stones from bowel disease. Endocrinol Metab Clin North Am 2002, 31:979-999.
104. Furth SL, Casey JC, Pyzik PL, et al. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol 2000, 15:125-128.
105. Scheinman SJ X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 1998, 53:3-17.
106. Charnas LR, Bernardini I, Rader D, et al. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med 1991, 324:1318-1325.
107. Sliman GA, Winters WD, Shaw DW, Avner ED Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome. J Urol 1995, 153:1244-1246.
108. Weber S, Schneider L, Peters M, et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2001, 12:1872-1881.
109. Zimmermann B, Plank C, Konrad M, et al. Hydrochlorothiazide in CLDN16 mutation. Nephrol Dial Transplant 2006, 21:2127-2132.
110. Hollingsworth JM, Rogers MA, Kaufman SR, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006, 368:1171-1179.
111. Knoll T, Zollner A, Wendt-Nordahl G, et al. Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow up. Pediatr Nephrol 2005, 20:19-24.
112. Joly D, Rieu P, Mejean A, et al. Treatment of cystinuria. Pediatr Nephrol 1999, 13:945-950.
113. Aldrigde RD, Aldridge RC, Aldridge LM Anesthesia for pediatric lithotripsy. Paediatr Anaesth 2006, 16:236-241.
114. Durkee CT, Balcom A Surgical management of urolithiasis. Pediatr Clin North Am 2006, 53:465-477.
115. Curhan GC, Willett WC, Knight EL, Stampfer MJ Dietary factors and the risk of incident kidney stones in younger women: Nurses Health Study II. Arch Intern Med 2004, 26:885-891.
116. Von Unruh GE, Voss S, Sauerbruch T, Hesse A Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol 2004, 15:1567-1573.
117. Laube N, Hoppe B, Hesse A Problems in the investigation of urines from patients suffering from primary hyperoxaluria type I. Urol Res 2005, 33:394-397.
118. Hatch M, Cornelius J, Allison M, et al. Oxalobacter sp. reduces urinary oxalate excretion promoting enteric oxalate excretion. Kidney Int 2006, 69:1-8.
119. Hoppe B, Beck B, Gatter N, et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type I. Kidney Int 2006, 70:1305-1311.
120. Danpure CJ Primary hyperoxaluria: from gene defects to designer drugs. Nephrol Dial Transplant 2005, 20:1525-1529.
121. Bunchman TE, Swartz RD Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD. Perit Dial Int 1994, 14:81-84.
122. Saborio P, Scheinman JI Transplantation for primary hyperoxaluria in the United States. Kidney Int 1999, 56:1094-1100.
123. Jamieson NV A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004. Am J Nephrol 2005, 25:282-289. European PHI Transplantation Study Group.
124. Nolkemper D, Kemper MJ, Burdelski M, et al. Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplant 2000, 3:177-181.
125. Hoppe B, Kemper MJ, Bokenkamp A, et al. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int 1999, 56:268-274.
126. Sakhaee K Pathogenesis and medical management of cystinuria. Semin Nephrol 1996, 16:435-437.
127. Werness PG, Brown CM, Smith LH, Finlayson B EQUIL 2, a BASIC computer program for the calculation of urinary saturation. J Urol 1985, 134:1242-1244.
128. Sharma SK, Indudhara R Chemodissolution of urinary uric acid stones by alkali therapy. Urol Int 1992, 48:81-86.
129. Hoffmann M, Talaszka A, Bocquet JP, et al. Acute renal failure and 2,8 dihydroxyadeninuria. Nephrologie 2004, 25:297-300.
130. Abrahams HM, Stoller ML Infection and urinary stones. Curr Opin Urol 2003, 13:63-67.
131. Dick PT, Shuckett BM, Tang B, et al. Observer reliability in grading nephrocalcinosis on ultrasound examinations in children. Pediatr Radiol 1999, 29:68-72.
132. Stapleton FB, Linshaw MA, Hassanein K, Gruskin AB Uric acid excretion in normal children. J Pediatr 1978, 92:911-914.
133. Tefekli A, Esen T, Ziylan O, et al. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?. Urol Int 2003, 70:273-277.